Prospera Private Wealth LLC purchased a new position in MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 717 shares of the financial services provider’s stock, valued at approximately $59,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in MET. Acadian Asset Management LLC bought a new stake in shares of MetLife during the first quarter worth $1,053,000. Edgestream Partners L.P. raised its stake in MetLife by 31.7% in the 1st quarter. Edgestream Partners L.P. now owns 7,002 shares of the financial services provider’s stock valued at $519,000 after acquiring an additional 1,684 shares during the period. Pitcairn Co. boosted its holdings in shares of MetLife by 5.6% during the first quarter. Pitcairn Co. now owns 5,751 shares of the financial services provider’s stock worth $426,000 after acquiring an additional 304 shares during the period. Natixis acquired a new position in shares of MetLife in the first quarter valued at about $224,000. Finally, CreativeOne Wealth LLC increased its stake in MetLife by 74.2% during the 1st quarter. CreativeOne Wealth LLC now owns 5,804 shares of the financial services provider’s stock worth $430,000 after acquiring an additional 2,472 shares during the period. 89.81% of the stock is owned by institutional investors.
MetLife Stock Up 3.3 %
Shares of MetLife stock opened at $85.35 on Friday. The stock’s 50-day moving average is $82.27 and its 200 day moving average is $75.91. MetLife, Inc. has a one year low of $62.15 and a one year high of $86.94. The firm has a market cap of $59.09 billion, a price-to-earnings ratio of 17.21, a PEG ratio of 0.75 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16.
MetLife Dividend Announcement
Analyst Ratings Changes
Several analysts recently weighed in on the company. Piper Sandler raised their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Wells Fargo & Company lifted their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Morgan Stanley reduced their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, TD Cowen began coverage on MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price for the company. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $88.46.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- How to Invest in the Best Canadian StocksĀ
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Most Volatile Stocks, What Investors Need to Know
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.